Shortages of Estradot (estradiol) transdermal patches to continue

Sandoz Pty Ltd has notified us that due to the manufacturing issues, the shortages of all strengths of Estradot estadiol transdermal patches have been extended. There are also shortages reported for Estalis (estradiol + norethisterone) transdermal patches.

The current return-to-supply dates for the different products are published on the Medicine Shortage Reports Database.

We have approved the supply of overseas-registered alternatives to Estradot 37.5 mcg, 50 mcg, 75 mcg and 100 mcg under section 19A of the Therapeutic Goods Act 1989. Up-to-date information about these products and how to order them is available on the Section 19A approvals database.

Important information for patients, carers, pharmacists and prescribers is available at About the shortage of transdermal HRT patches.